Literature DB >> 1477791

The thermostable direct hemolysin of Vibrio parahaemolyticus is a pore-forming toxin.

T Honda1, Y Ni, T Miwatani, T Adachi, J Kim.   

Abstract

The hemolytic mechanism of thermostable direct hemolysin (TDH), a possible virulence factor of Vibrio parahaemolyticus, was studied. We demonstrated that TDH acts as a "pore-forming toxin" in temperature-dependent and -independent steps. The first temperature-dependent step requires only about 1-2 min incubation at 37 degrees C and makes a "pore" with a functional diameter of approximately 2 nm. The pore size was deduced from the molecular diameter of the colloidal inhibitory polysaccharides. The formation of the pores on TDH-treated erythrocyte membranes was also demonstrated by electron microscopic examination. The second step, which is a temperature-independent lytic step, causes the erythrocytes to swell owing to a colloidal osmotic influx of water via the "pores" into cells, resulting in erythrocyte lysis (or rupture) owing to increased intracellular pressure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1477791     DOI: 10.1139/m92-192

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN: 0008-4166            Impact factor:   2.419


  29 in total

1.  Vibrio parahaemolyticus thermostable direct hemolysin modulates cytoskeletal organization and calcium homeostasis in intestinal cultured cells.

Authors:  A Fabbri; L Falzano; C Frank; G Donelli; P Matarrese; F Raimondi; A Fasano; C Fiorentini
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Cl(-) secretion in colonic epithelial cells induced by the vibrio parahaemolyticus hemolytic toxin related to thermostable direct hemolysin.

Authors:  A Takahashi; N Kenjyo; K Imura; Y Myonsun; T Honda
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

3.  Hyperproduction, purification, and mechanism of action of the cytotoxic enterotoxin produced by Aeromonas hydrophila.

Authors:  M R Ferguson; X J Xu; C W Houston; J W Peterson; D H Coppenhaver; V L Popov; A K Chopra
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

4.  Differential Recognition of Vibrio parahaemolyticus OmpU by Toll-Like Receptors in Monocytes and Macrophages for the Induction of Proinflammatory Responses.

Authors:  Aakanksha Gulati; Ranjai Kumar; Arunika Mukhopadhaya
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

Review 5.  Role of pore-forming toxins in bacterial infectious diseases.

Authors:  Ferdinand C O Los; Tara M Randis; Raffi V Aroian; Adam J Ratner
Journal:  Microbiol Mol Biol Rev       Date:  2013-06       Impact factor: 11.056

6.  Effect on human cells of environmental Vibrio parahaemolyticus strains carrying type III secretion system 2.

Authors:  Greta Caburlotto; Maria M Lleò; Tamara Hilton; Anwar Huq; Rita R Colwell; James B Kaper
Journal:  Infect Immun       Date:  2010-05-17       Impact factor: 3.441

7.  Cation flux studies of the lesion induced in human erythrocyte membranes by the thermostable direct hemolysin of Vibrio parahaemolyticus.

Authors:  J S Huntley; A C Hall; V Sathyamoorthy; R H Hall
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Vibrio parahaemolyticus inhibition of Rho family GTPase activation requires a functional chromosome I type III secretion system.

Authors:  Timothy Casselli; Tarah Lynch; Carolyn M Southward; Bryan W Jones; Rebekah DeVinney
Journal:  Infect Immun       Date:  2008-03-17       Impact factor: 3.441

Review 9.  Vibrio fluvialis: an unusual enteric pathogen of increasing public health concern.

Authors:  Etinosa O Igbinosa; Anthony I Okoh
Journal:  Int J Environ Res Public Health       Date:  2010-10-12       Impact factor: 3.390

10.  Association of Vibrio parahaemolyticus thermostable direct hemolysin with lipid rafts is essential for cytotoxicity but not hemolytic activity.

Authors:  Shigeaki Matsuda; Toshio Kodama; Natsumi Okada; Kanna Okayama; Takeshi Honda; Tetsuya Iida
Journal:  Infect Immun       Date:  2009-11-23       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.